Name | Equities | % | Valuation |
Royalty Pharma PLC Class B | 7,447,141 | 3.09% | 317,099,264 USD |
RPI US PARTNERS 2019 LP | 6,691,882 | 3.13% | 284,940,336 USD |
Royalty Pharma plc (RPRX) (Pharmaceuticals) | 1,646,820 | 0.38% | 70,121,596 USD |
RPI International Holdings 2019 LP | 20,500 | 0.074% | 872,890 USD |
|